Switching from Reference to Biosimilar Filgrastim in Pediatric Patients

Details

Files

Project Status:

Completed

Project Line:

Reference List

Project Sub Line:

Summary of Abstracts

Project Number:

RB1575-000

Question

1. What is the clinical effectiveness of switching from reference to biosimilar filgrastim in pediatric patients? 2. What is the comparative clinical effectiveness of biosimilar Nivestym versus biologic Neupogen for pediatric patients?

Key Message

No relevant literature was identified regarding the clinical effectiveness of switching from reference to biosimilar filgrastim in pediatric patients. No relevant literature was identified regarding the comparative clinical effectiveness of biosimilar Nivestym versus biologic Neupogen for pediatric patients.

Files

Switching from Reference to Biosimilar Filgrastim in Pediatric Patients View PDF

Last Updated : June 2, 2021